202
Participants
Start Date
February 28, 2011
Primary Completion Date
October 31, 2012
Study Completion Date
October 31, 2012
Ranibizumab
Liquid ranibizumab (10 mg/ml) was supplied in a sterile solution in single-use vials.
Rochester
Pittsburgh
Pittsburgh
Camp Hill
Philadelphia
Baltimore
Hagerstown
Charlotte
West Columbia
Ladson
Augusta
Altamonte Springs
Boynton Beach
Lakeland
Nashville
Jackson
Edina
Rapid City
Chicago
Houston
The Woodlands
San Antonio
Austin
Abilene
Golden
Colorado Springs
Phoenix
Tucson
Las Vegas
Beverly Hills
Torrance
Santa Ana
Santa Barbara
Mountain View
San Francisco
Oakland
Chico
New London
Boston
Worcester
Northfield
Teaneck
Lead Sponsor
Genentech, Inc.
INDUSTRY